BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 29779136)

  • 41. Incidence of IP and risk of malignant transformation in the Swedish population 1960-2010.
    Elliot A; Marklund L; Håkansson N; Song H; Ye W; Stjärne P; Hammarstedt-Nordenvall L
    Eur Arch Otorhinolaryngol; 2017 Mar; 274(3):1445-1448. PubMed ID: 27757542
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Pattern of expression of cyclooxygenase-2 in malignant transformation of sinonasal inverted papilloma.
    Lee GH; Yoon YH; Kim YM; Yeo MK; Liang ZL; Kim JM; Rha KS
    Am J Otolaryngol; 2012; 33(5):585-9. PubMed ID: 22534023
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Histopathological parameters of recurrence and malignant transformation in sinonasal inverted papilloma.
    Katori H; Nozawa A; Tsukuda M
    Acta Otolaryngol; 2006 Feb; 126(2):214-8. PubMed ID: 16428203
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Altered expression of E-cadherin and β-catenin in malignant transformation of sinonasal inverted papillomas.
    Koo BS; Jung BJ; Kim SG; Liang ZL; Yeong MK; Rha KS
    Rhinology; 2011 Oct; 49(4):479-85. PubMed ID: 21991576
    [TBL] [Abstract][Full Text] [Related]  

  • 45. p53 alteration and human papilloma virus infection in paranasal sinus cancer.
    Caruana SM; Zwiebel N; Cocker R; McCormick SA; Eberle RC; Lazarus P
    Cancer; 1997 Apr; 79(7):1320-8. PubMed ID: 9083153
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Transcriptionally Active HPV and Targetable EGFR Mutations in Sinonasal Inverted Papilloma: An Association Between Low-risk HPV, Condylomatous Morphology, and Cancer Risk?
    Mehrad M; Stelow EB; Bishop JA; Wang X; Haynes W; Oliver D; Chernock RD; Lewis JS
    Am J Surg Pathol; 2020 Mar; 44(3):340-346. PubMed ID: 31743131
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Comprehensive analysis of HPV infection, EGFR exon 20 mutations and LINE1 hypomethylation as risk factors for malignant transformation of sinonasal-inverted papilloma to squamous cell carcinoma.
    Sahnane N; Ottini G; Turri-Zanoni M; Furlan D; Battaglia P; Karligkiotis A; Albeni C; Cerutti R; Mura E; Chiaravalli AM; Castelnuovo P; Sessa F; Facco C
    Int J Cancer; 2019 Mar; 144(6):1313-1320. PubMed ID: 30411788
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Immunohistochemistry of p53 in sinonasal inverted papilloma and associated squamous cell carcinoma.
    Fang SY; Yan JJ; Ohyama M
    Am J Rhinol; 1998; 12(2):119-24. PubMed ID: 9578930
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Sine Qua Non: Sinonasal Inverted Papilloma.
    Jewett FC; Coulter MJ; Nelson BL
    Head Neck Pathol; 2021 Sep; 15(3):950-954. PubMed ID: 33544382
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Histological features and malignant transformation of inverted papilloma.
    Eggers G; Eggers H; Sander N; Kössling F; Chilla R
    Eur Arch Otorhinolaryngol; 2005 Apr; 262(4):263-8. PubMed ID: 15258811
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Inverted papilloma of paranasal sinuses.
    Eggers G; Mühling J; Hassfeld S
    J Craniomaxillofac Surg; 2007 Jan; 35(1):21-9. PubMed ID: 17267229
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Nasal inverted papilloma and human papilloma virus].
    Wang D; Li Y; Sun K
    Lin Chuang Er Bi Yan Hou Ke Za Zhi; 1998 Mar; 12(3):118-9. PubMed ID: 11189134
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Schneiderian papillomas: comparative review of exophytic, oncocytic, and inverted types.
    Vorasubin N; Vira D; Suh JD; Bhuta S; Wang MB
    Am J Rhinol Allergy; 2013; 27(4):287-92. PubMed ID: 23883810
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Long-term outcomes in sinonasal squamous cell carcinoma arising from inverted papilloma: Systematic review.
    Birkenbeuel JL; Pang JC; Lee A; Nguyen ES; Risbud A; Goshtasbi K; Abiri A; Lehrich BM; Tong CCL; Adappa ND; Palmer JN; Kuan EC
    Head Neck; 2022 Apr; 44(4):1014-1029. PubMed ID: 35141984
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Association between human papillomavirus infection and malignant transformation of sinonasal inverted papilloma: A systematic review and meta-analysis.
    Ferreli F; Di Bari M; Moya-Plana A; Canzano F; Morenghi E; De Virgilio A; Mercante G; Spriano G; Colombo G
    Am J Otolaryngol; 2022; 43(6):103614. PubMed ID: 36113312
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Human papillomavirus (HPV) transcripts in malignant inverted papilloma are from integrated HPV DNA.
    McKay SP; Grégoire L; Lonardo F; Reidy P; Mathog RH; Lancaster WD
    Laryngoscope; 2005 Aug; 115(8):1428-31. PubMed ID: 16094117
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Expression pattern of apurinic/apyrimidinic endonuclease in sinonasal squamous cell carcinoma.
    Lee JW; Jin J; Rha KS; Kim YM
    Otolaryngol Head Neck Surg; 2012 Oct; 147(4):788-95. PubMed ID: 22645113
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Preoperative Prediction of Sinonasal Inverted Papilloma-associated Squamous Cell Carcinoma (IP-SCC).
    Park MJ; Cho W; Kim JH; Chung YS; Jang YJ; Yu MS
    Laryngoscope; 2023 Oct; 133(10):2502-2510. PubMed ID: 36683553
    [TBL] [Abstract][Full Text] [Related]  

  • 59. HPV Infection is Associated with FoxM1 Overexpression in Dysplastic Changes of Sinonasal Inverted Papilloma.
    Rachmadi L; Billianti Susanto YD; Sitinjak D; Manatar AF; Saraswati M; Adham M
    Asian Pac J Cancer Prev; 2022 Dec; 23(12):4293-4298. PubMed ID: 36580012
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Activating KRAS mutations are characteristic of oncocytic sinonasal papilloma and associated sinonasal squamous cell carcinoma.
    Udager AM; McHugh JB; Betz BL; Montone KT; Livolsi VA; Seethala RR; Yakirevich E; Iwenofu OH; Perez-Ordonez B; DuRoss KE; Weigelin HC; Lim MS; Elenitoba-Johnson KS; Brown NA
    J Pathol; 2016 Aug; 239(4):394-8. PubMed ID: 27234382
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.